Using this three-stage design, we demonstrated that pharmacological inhibition of MMP12 produces coordinated antimigratory, anti-clonogenic, and pro-apoptotic effects in NSCLC cells. The gene discussed is MMP12; the disease is non-small cell lung carcinoma.